RangaswamyGovindarajanMD

Oncology • Little Rock, AR

Professor, Internal Medicine, University of Arkansas COM

Join to view full profile

Dr. Govindarajan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Govindarajan's full profile

Already have an account?

Office
John L. McClellan Memorial Veterans' Hospital, UAMS Medical Center
449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Seventh Floor
Little Rock, AR 72205
Phone+1 501-686-8530
Is this information wrong?

Summary

Dr. Rangaswamy Govindarajan is an oncologist in Little Rock, AR and is affiliated with multiple hospitals in the area, including John L. McClellan Memorial Veterans Hospital, Ashley County Medical Center, and UAMS Medical Center. He received his medical degree from Mysore Medical College and has been in practice 37 years. He specializes in hematologic oncology.

Education & Training

University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 1993 - 1996
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1992 - 1993
Mysore Medical CollegeClass of 1980

Certifications & Licensure

AR State Medical License 1993 - 2024
FL State Medical License 2002 - 2005

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma Start of enrollment: 2006 Feb 01
Completed
Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer Start of enrollment: 2011 Nov 01
Completed
Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth Start of enrollment: 2012 Aug 01
Terminated
Phase 2
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

7 citations
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation.
Cathy Eng, Emerson Y. Chen, Jane E. Rogers, Mark A. Lewis, Jonathan R. Strosberg, Ramya Thota, Smitha S. Krishnamurthi, Paul E. Oberstein, Rang Govindarajan, Gary L. B...> ;JCO Oncology Practice. 2021 Feb 3
65 citations
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
Alain Algazi, Megan Othus, Adil Daud, Roger S. Lo, Janice M. Mehnert, Thach Giao Truong, Robert M. Conry, Kari Kendra, Gary C. Doolittle, Joseph I. Clark, Michael J. M...> ;Nature Medicine. 2020 Oct 5
3 citations
Incidence and Management of Olaratumab Infusion-Related Reactions.
Brian A. Van Tine, Rangaswamy Govindarajan, Steven Attia, Neeta Somaiah, Scott S. Barker, Ashwin Shahir, Emily Barrett, Pablo Lee, Volker Wacheck, Samuel Cowan Ramage,...> ;Journal of Oncology Practice. 2019 Jul 3
Integrating Collaborative Learning and Competition in a Hematology/Oncology Training Program.
Issam Makhoul, Pooja Motwani, Liudmila Schafer, Konstantinos Arnaoutakis, Fade Mahmoud, Mazin Safar, Dorothy A. Graves, Paulette Mehta, Rang Govindarajan, Laura F. Hut...> ;Journal of Cancer Education. 2018 Feb 1
32 citations
Programmed Cell Death-ligand 1 (pd-l1) Expression in Anal Cancer
Rangaswamy Govindarajan, Swetha Gujja, Eric R. Siegel, Anu Batra, Anwaar Saeed, Keith Lai, Jennifer D James, Bradley J Fogel, Stephen K. Williamson> ;American Journal of Clinical Oncology. 2016 Nov 15
8 citations
A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.
Rangaswamy Govindarajan, James Posey, Calvin Y. Chao, Ruixiao Lu, Trafina Jadhav, Ahmed Y. Javed, Awais Javed, Fade Mahmoud, Raymond U. Osarogiagbon, Upender Manne> ;BMC Cancer. 2016 Jun 18
An Unusual Case of Gastric Cancer with Bone Marrow Metastases and Embolic Phenomena as Initial Presentation.
Harjot Kaur, Appalanaidu Sasapu, Jeanette M Ramos, Rangaswamy Govindarajan> ;Journal of Gastrointestinal Cancer. 2015 Apr 10
2 citations
MYC amplification in multiple marker chromosomes and EZH2 microdeletion in a man with acute myeloid leukemia
Zhifu Xiang, Al-Ola Abdallah, Rangaswamy Govindarajan, Paulette Mehta, Peter D. Emanuel, Peter Papenhausen, Steven A. Schichman> ;Cancer Genetics. 2015 Mar 1
3 citations
Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases ...
Abby E Holt, Muhammad Atif Khan, Swetha Gujja, Rangaswamy Govindarajan> ;Cancer Management and Research. 2014 Dec 24
18 citations
Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia
Varinder Kaur, Paulette Mehta, Joyce Johnsurd, Rangaswamy Govindarajan> ;Blood. 2014 Nov 27
27 citations
Bevacizumab and erlotinib in previously untreated inoperable and metastatic hepatocellular carcinoma.
Rangaswamy Govindarajan, Eric R. Siegel, Issam Makhoul, Stephen K. Williamson> ;American Journal of Clinical Oncology. 2013 Jun 1
1 citations
Biliary Actinomycosis Mimicking a Klatskin Tumor
Meghana Bansal, Abhishek Agarwal, Ryan Bariola, Farshad Aduli, Rangaswamy Govindarajan> ;Journal of Gastrointestinal Cancer. 2012 Sep 1
118 citations
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
Anthony B. El-Khoueiry, Cathryn Rankin, Edgar Ben-Josef, Heinz-Josef Lenz, Philip J. Gold, R. Darryl Hamilton, Rangaswamy Govindarajan, Cathy Eng, Charles D. Blanke> ;Investigational New Drugs. 2012 Aug 1
4 citations
Ectopic Adrenocorticotropic Hormone Syndrome Due to a Pancreatic Neuroendocrine Tumor
Meghana Bansal, Abhishek Agarwal, Rangaswamy Govindarajan> ;Journal of Gastrointestinal Cancer. 2012 Jun 26
Cetuximab-related infusion reaction rate in cancer patients differs by race.
Kiwan EN, Siegel E, Hutchins LF, Maddox A, Govindarajan R, Safar AM, Makhoul I> ;J. Clin. Oncol.. 2011-05-20
The effect of metformin (M) on overall survival (OS) of patients (Pts) with colorectal cancer (CRC) treated with chemotherapy (CTX).
Bansal M, Siegel E, Govindarajan R> ;J. Clin. Oncol.. 2011-05-20
Effect of metformin alone and in combination with 5-fluorouracil (5FU), oxaliplatin (O) and irinotecan (I) on human colon cancer cell lines.
Kunthur A, Aldwairi A, Simmen F, Govindarajan R> ;J. Clin. Oncol.. 2011-05-20
Efficacy and safety of administration of gemcitabine and docetaxel with radiation therapy in patients with high-grade soft tissue sarcoma.
Raval GG, Govindarajan R> ;J. Clin. Oncol.. 2009-05-20
Phase II study of efficacy of bevacizumab and erlotinib in inoperable previously untreated hepatocellular carcinoma (HCC).
Govindarajan R, Siegel E, Makhoul I, Williamson S> ;J. Clin. Oncol.. 2009-05-20
The impact of lymph node ratio (LNR) on survival in patients with colorectal cancer.
Gentry RW, Spencer H, Dykstra-Long G, Govindarajan R> ;J. Clin. Oncol.. 2008-05-20
Thiazolidinedione (TZD) exposure and overall survival (OS) in squamous cell carcinoma of the head and neck (SCCHN).
Govindarajan R, Siegel ER, Simmons DL, Lang NP> ;J. Clin. Oncol.. 2008-05-20
Heparin-induced skin necrosis associated with thrombocytopenia and acquired protein C and protein S deficiency.
H. Keshava Prasad, Rangaswamy Govindarajan> ;American Journal of Hematology. 2007 Dec 1
258 citations
Thiazolidinediones and the Risk of Lung, Prostate, and Colon Cancer in Patients With Diabetes
Rangaswamy Govindarajan, Luke Ratnasinghe, Debra L. Simmons, Eric R. Siegel, Madhu V. Midathada, Lawrence T. Kim, Peter J. Kim, Randall J. Owens, Nicholas P. Lang> ;Journal of Clinical Oncology. 2007 Apr 20
6 citations
Barriers to clinical trials vary according to the type of trial and the institution
Rangaswamy Govindarajan, James W. Young, Cherie L. Harless, Laura F. Hutchins> ;Journal of Clinical Oncology. 2007 Apr 20
88 citations
Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006.
Rangaswamy Govindarajan, Josna Adusumilli, Donna L. Baxter, Anthony B. El-Khoueiry, Sami I. Harik> ;Journal of Clinical Oncology. 2006 Oct 1
Join now to see all

Press Mentions

New UAMS Baptist Health Cancer Center Opens in North Little RockAugust 30th, 2021

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

John L. McClellan Memorial Veterans' HospitalLittle Rock, Arkansas
UAMS Medical CenterLittle Rock, Arkansas